FluroTest Provides System Development Update; Reports Saliva-based Point of Access Test System and Immunoassay for SARS-CoV-2 Detection is Fully Functional bit.ly/3kgEcAy

FluroTest Announces Pre-Emergency Use Authorization Filing with FDA; Provides Executive Update on Program Progress bit.ly/3ka5CIU

FluroTech Announces Closing of Amalgamation bit.ly/3ynvSUG

FluroTech Announces Warrant Incentive Program Results Adding Over $1M to Company Treasury bit.ly/2QfWhT6

FluroTech Announces Extension to Early Warrant Exercise Incentive Program bit.ly/3uun3WT

FluroTech Announces Early Warrant Exercise Incentive Program bit.ly/3a1j0cn

FluroTech and FluroTest Announce Definitive Amalgamation Agreement bit.ly/3qPjxDG

FluroTech Partners With Toolbox Medical Innovations for Clinical Trial of Mass-Scale COVID-19 Testing Platform bit.ly/3qk9lTs

Robotics Automation Pioneer Phillip Farrelly Joins Flurotech Scientific Advisory Board bit.ly/3q2mgt3

FluroTech and Hudson Robotics Begin Pandemic Response Unit Pre-Production bit.ly/2ZvTfLA

FluroTech Adds Life Sciences Expert Dr. Timothy J. Holzer to Scientific Advisory Board bit.ly/2Zp9xFO

FluroTech Expands nanoComposix Mandate; Initiating Covid-19 Test Performance Evaluation and Validation bit.ly/3odRWuB

FluroTech Announces Appointment of Regulatory Consultant bit.ly/2LMUP8c

FluroTech Announces Closing of First Tranche of Private Placement bit.ly/3oE22WI

FluroTech Announces Non-Brokered Private Placement of Units bit.ly/3gmSETT

FluroTest Systems Ltd. Releases White Paper on the Evolving Role of Antigen Testing in the COVID-19 Pandemic Response bit.ly/3lJwxZf

FluroTech Announces Product Solution to Safely Open Universities, Colleges, as Well as Primary and Secondary Schools bit.ly/3g187c5

FluroTech Announces Its Safe Air Travel Product Solution bit.ly/3fgtohN

FluroTech Announces Stadium and Arena Product Solution bit.ly/35BH8jS